Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1984 Oct;18(1):49–53. doi: 10.1007/BF00205399

Antitumor and antimetastatic activity of the immunoadjuvant peptidoglycan monomer PGM in mice bearing MCa mammary carcinoma

Gianni Sava 1,2, Jelka Tomašic 3,2, Ivo Hršak 3,2
PMCID: PMC11039097  PMID: 6567478

Abstract

The antitumor and antimetastatic activities of the water-soluble peptidoglycan monomer GlnNAc-Mur-NAc-L-Ala-D-iso-Gln-meso-diamminopimelic acid (θ-NH2)-D-Ala-D-Ala (PGM), which has immunostimulant effects, have been evaluated in CBA mice bearing MCa mammary carcinoma. The antineoplastic effects of PGM depend strictly on the dosage and treatment schedule used. Though a significant inhibition of the primary tumor growth is observed over a wide range of dosage, only the IV administration of daily doses of 50 mg/kg/day on days 1, 5, 10, 15 inhibits spontaneous lung metastasis formation and in parallel prolongs the survival time of the treated mice. The magnitude of the antimetastatic effects of PGM depends on the degree of dissemination of the tumor, and is greater when the number of metastatic foci is low. Examination of the therapeutic potential of PGM in combination with surgery has further indicated that the timing of administration plays an important role in the overall effectiveness of this substance. A 5-day interval is necessary between two consecutive injections for the induction of significant increases of the survival times.

Keywords: Survival Time, Lung Metastasis, Peptidoglycan, Treated Mouse, Metastasis Formation

References

  • 1.Baldwin RW. Manipulation of host resistance in cancer therapy. Semin Immunopathol. 1982;5:113–125. doi: 10.1007/BF00199791. [DOI] [PubMed] [Google Scholar]
  • 2.Fidler IJ, Sone S, Fogler WE, Barnes ZL. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA. 1981;78:1680–1684. doi: 10.1073/pnas.78.3.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Giraldi T, Sava G, Cuman R, Nisi C, Lassiani L. Selectivity of the antimetastatic and cytotoxic effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt, (±)1,2-di-(3,5-dioxopiperazin-1-yl)propane and cyclophosphamide in mice bearing Lewis lung carcinoma. Cancer Res. 1981;41:2524–2528. [PubMed] [Google Scholar]
  • 4.Hršak I, Tomašić J, Pavelić K, Valinger Z. Stimulation of humoral immunity by peptidoglycan monomer from Brevibacterium divaricatum . Z Immunitaetsforsch Immunobiol. 1978;155:312–318. [PubMed] [Google Scholar]
  • 5.Hršak I, Novak D, Tomašić J. Immunostimulating activity of peptidoglycan monomer (PGM) on in vivo primary response to sheep erythrocytes, Salmonella typhymurium and Newcastle disease virus. Period Biol. 1980;82:147–151. [Google Scholar]
  • 6.Hršak I, Tomašić J, Osmak M. Immunotherapy of B-16 melanoma with peptidoglycan monomer. Eur J Cancer Clin Oncol. 1983;19:681–686. doi: 10.1016/0277-5379(83)90185-2. [DOI] [PubMed] [Google Scholar]
  • 7.Ikekawa T, Ikeda Y, Tukuoka F. Antitumor activity of polysaccharides from Serratia marcescens . Gann. 1975;66:317–318. [PubMed] [Google Scholar]
  • 8.Keglević D, Ladešić B, Hadzija O, Tomašić J, Valinger Z, Pokorny M, Naumski R. Isolation and study of the composition of a peptidoglycan complex excreted by the biotin-requiring mutant of Brevibacterium divaricatum NRRL-2311 in the presence of penicillin. Eur J Biochem. 1974;42:389–400. doi: 10.1111/j.1432-1033.1974.tb03351.x. [DOI] [PubMed] [Google Scholar]
  • 9.Keglević D, Ladešic B, Tomašić J, Valinger Z, Naumski R. Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant. Biochim Biophys Acta. 1979;585:273–281. doi: 10.1016/0304-4165(79)90027-8. [DOI] [PubMed] [Google Scholar]
  • 10.Leibovici J, Michiwitz M, Shezen E, Wolman M, Sandbank U. Combined treatment of Lewis lung carcinoma by tumor excision and levan. Oncology. 1981;38:31–34. doi: 10.1159/000225517. [DOI] [PubMed] [Google Scholar]
  • 11.Nakahara W, Fukuota F, Maeda Y, Aoki K. The host-mediated antitumor effect of some plant polysaccharides. Gann. 1964;55:283–288. [PubMed] [Google Scholar]
  • 12.North RJ, Dye ES, Mills CD, Chandler JP. Modulation of antitumor immunity — immunobiological approaches. Semin Immunopathol. 1982;5:193–220. doi: 10.1007/BF00199796. [DOI] [PubMed] [Google Scholar]
  • 13.Poliak-Blazi M, Boranić M, Marzan B, Radačić M. A transplantable aplastic mammary carcinoma of CBA mice. Veterinarski Arhiv. 1981;51:99–107. [Google Scholar]
  • 14.Sadler TE, Castro JE. The effects of Corynebaterium parvum and surgery on Lewis lung carcinoma and its metastases. Br J Surgery. 1976;63:292–296. doi: 10.1002/bjs.1800630410. [DOI] [PubMed] [Google Scholar]
  • 15.Sava G, Giraldi T, Lassiani L, Nisi C. Mechanism of the antimetastatic action of dimethyltriazenes. Cancer Treat Rep. 1979;63:93–98. [PubMed] [Google Scholar]
  • 16.Sava G, Giraldi T, Nisi C, Bertoli G. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma. Cancer Treat Rep. 1982;66:115–120. [PubMed] [Google Scholar]
  • 17.Sava G, Giraldi T, Tomašić J, Hršak I. Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM) Cancer Immunol Immunother. 1983;15:84–86. doi: 10.1007/BF00199695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sokal RR, Rohlf FJ. Biometry. San Francisco: Freeman; 1969. Single classification analysis of variance; pp. 204–252. [Google Scholar]
  • 19.Trešceć A, Iskrić S, Hršak I, Tomašić J. Effect of immunoadjuvant peptidoglycan monomer on liver cytochrome P-450. Biochem Pharmacol. 1983;32:2354–2357. doi: 10.1016/0006-2952(83)90187-9. [DOI] [PubMed] [Google Scholar]
  • 20.Usui S, Urano M, Koike S, Kobayashi Y. Effects of PS-K, a protein polysaccharide, on pulmonary metastases of C3H mouse squamous cell carcinoma. J Natl Cancer Inst. 1976;56:185–187. doi: 10.1093/jnci/56.1.185. [DOI] [PubMed] [Google Scholar]
  • 21.Yamamoto T, Yamashita T, Tsubura E. Inhibition of pulmonary metastasis of Lewis lung carcinoma by glucan, schizophyllan. Invasion Metastasis. 1981;1:71–84. [PubMed] [Google Scholar]
  • 22.Yarkoni E, Lederer E, Rapp HJ. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimicolate. Infect Immun. 1981;32:273–276. doi: 10.1128/iai.32.1.273-276.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES